Oramed Pharmaceuticals Inc. (ORMP) stock
ORMPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/30
$3.71−0.32 (-7.94%)
Close on Nov 13, 2026Market cap $154.33MP/E 1.1Yield 6.74%
Oramed Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Oramed Pharmaceuticals's enterprise value was $154.54M on Nov 11, 2026, against $58.30M a year earlier. Over the last 5 years it ranged from -$55.17M to $421.64M, with a median of $89.34M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $154.54M | +165.1% |
| 2025 | Dec 31, 2025 | $58.30M | – |
| 2024 | Dec 31, 2024 | -$3.17M | -102.0% |
| 2023 | Dec 29, 2023 | $162.00M | -52.7% |
| 2022 | Dec 30, 2022 | $342.23M | -18.8% |
| 2021 | Dec 31, 2021 | $421.64M | +442.0% |
| 2020 | Dec 31, 2020 | $77.79M | -8.7% |
| 2019 | Dec 31, 2019 | $85.20M | +89.5% |
| 2018 | Dec 31, 2018 | $44.97M | -61.3% |
| 2017 | Dec 29, 2017 | $116.19M | +57.2% |
| 2016 | Dec 30, 2016 | $73.92M | -21.0% |
| 2015 | Dec 31, 2015 | $93.56M | +116.3% |
| 2014 | Dec 31, 2014 | $43.26M | -63.7% |
| 2013 | Dec 31, 2013 | $119.25M | +447.1% |
| 2012 | Dec 31, 2012 | $21.80M | +22.9% |
| 2011 | Dec 30, 2011 | $17.73M | – |
See a number that looks wrong?